Skip to content
HowShorted

Viridian Therapeutics, Inc.\DE short interest in 2021

In 2021, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 1.54% of shares outstanding on 15 Apr 2021 to 1.53% on 31 Dec 2021, a change of -0.01 percentage points. The year's high was 1.62% on 14 May 2021 and its low 0.56% on 15 Sep 2021, averaging 1.06% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.02 days on 14 May 2021. Full history: Viridian Therapeutics, Inc.\DE.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Viridian Therapeutics, Inc.\DE in 2021

2021 in figures

Start of year
1.54% (15 Apr 2021)
End of year
1.53% (31 Dec 2021)
Change
-0.01 pp
High
1.62% (14 May 2021)
Low
0.56% (15 Sep 2021)
Average
1.06%
Highest days to cover
11.02 (14 May 2021)
SEC filings marked
8

Every report in 2021

Viridian Therapeutics, Inc.\DE short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Apr 20211.54%4.14results (8-K), 10-K filed
30 Apr 20211.17%1.42
14 May 20211.62%11.02results (8-K), 10-Q filed
28 May 20210.98%2.17
15 Jun 20211.21%2.35
30 Jun 20211.12%1.83
15 Jul 20211.10%6.80
30 Jul 20211.04%10.38
13 Aug 20210.68%4.33results (8-K), 10-Q filed
31 Aug 20210.58%1.00
15 Sep 20210.56%1.00
29 Oct 20211.39%1.58
15 Nov 20210.65%1.86results (8-K), 10-Q filed
30 Nov 20210.73%2.21
15 Dec 20211.06%2.07
31 Dec 20211.53%1.86

See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.